AB
JAZZ icon

Amalgamated Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Amalgamated Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.68M Sell
27,706
-1,905
-6% -$417K 0.05% 322
2026
Q1 		$5.6M Buy
29,611
+2,097
+8% +$366K 0.04% 372
2025
Q4 		$4.68M Sell
27,514
-58
-0.2% -$8.89K 0.03% 447
2025
Q3 		$3.63M Sell
27,572
-441
-2% -$52.9K 0.03% 558
2025
Q2 		$2.97M Buy
28,013
+427
+2% +$46.4K 0.02% 633
2025
Q1 		$3.42M Sell
27,586
-1,217
-4% -$159K 0.03% 540
2024
Q4 		$3.55M Sell
28,803
-641
-2% -$75.5K 0.03% 548
2024
Q3 		$3.28M Sell
29,444
-9,681
-25% -$1.06M 0.03% 596
2024
Q2 		$4.18M Buy
39,125
+1,745
+5% +$192K 0.04% 509
2024
Q1 		$4.5M Sell
37,380
-3,549
-9% -$435K 0.04% 507
2023
Q4 		$5.03M Sell
40,929
-877
-2% -$109K 0.04% 471
2023
Q3 		$5.41M Sell
41,806
-1,648
-4% -$220K 0.05% 398
2023
Q2 		$5.39M Buy
43,454
+432
+1% +$58.1K 0.04% 391
2023
Q1 		$6.29M Sell
43,022
-2,640
-6% -$391K 0.05% 330
2022
Q4 		$7.27M Buy
45,662
+495
+1% +$72.5K 0.06% 293
2022
Q3 		$6.02M Buy
45,167
+1,408
+3% +$214K 0.06% 304
2022
Q2 		$6.83M Buy
43,759
+1,469
+3% +$226K 0.06% 281
2022
Q1 		$6.58M Sell
42,290
-1,485
-3% -$215K 0.05% 341
2021
Q4 		$5.58M Sell
43,775
-1,530
-3% -$201K 0.04% 452
2021
Q3 		$5.9M Sell
45,305
-3,842
-8% -$580K 0.05% 400
2021
Q2 		$8.73M Buy
49,147
+42,276
+615% +$7.32M 0.07% 261
2021
Q1 		$1.13M Sell
6,871
-337
-5% -$55.5K 0.04% 481
2020
Q4 		$1.19M Buy
7,208
+21
+0.3% +$3.13K 0.05% 436
2020
Q3 		$1.02M Buy
7,187
+450
+7% +$55.8K 0.04% 432
2020
Q2 		$743K Sell
6,737
-7,423
-52% -$821K 0.03% 574
2020
Q1 		$1.41M Sell
14,160
-321
-2% -$41.5K 0.03% 487
2019
Q4 		$2.16M Buy
14,481
+749
+5% +$102K 0.04% 465
2019
Q3 		$1.76M Buy
13,732
+1,613
+13% +$216K 0.04% 503
2019
Q2 		$1.73M Sell
12,119
-1,122
-8% -$151K 0.04% 481
2019
Q1 		$1.89M Buy
13,241
+253
+2% +$33K 0.05% 410
2018
Q4 		$1.61M Buy
12,988
+4,680
+56% +$694K 0.05% 412
2018
Q3 		$1.4M Sell
8,308
-5,215
-39% -$897K 0.03% 513
2018
Q2 		$2.33M Buy
+13,523
New +$2.21M 0.06% 316
2016
Q2 		– Sell
-2,020
Closed -$264K – 1394
2016
Q1 		$264K Buy
2,020
+578
+40% +$71.9K 0.03% 967
2015
Q4 		$203K Sell
1,442
-466
-24% -$64.6K 0.03% 1070
2015
Q3 		$253K Buy
1,908
+47
+3% +$8.09K 0.03% 1003
2015
Q2 		$328K Sell
1,861
-4,858
-72% -$872K 0.03% 900
2015
Q1 		$1.16M Buy
6,719
+229
+4% +$39.3K 0.14% 148
2014
Q4 		$1.06M Buy
6,490
+35
+0.5% +$5.81K 0.17% 119
2014
Q3 		$1.04M Buy
6,455
+57
+0.9% +$8.76K 0.15% 131
2014
Q2 		$941K Buy
6,398
+548
+9% +$76K 0.14% 146
2014
Q1 		$811K Sell
5,850
-44
-0.7% -$6.62K 0.14% 154
2013
Q4 		$746K Buy
+5,894
New +$610K 0.13% 173

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Amalgamated Bank's JAZZ Position: Q2 2026 in Review

Amalgamated Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 6.4% in Q2 2026, selling an estimated $417K and leaving 27,706 shares worth $6.68M. The position accounts for 0.05% of the portfolio, ranked #322.

Amalgamated Bank first reported a position in JAZZ in Q4 2013 and has held it in 43 quarters since. The position peaked at $8.73M in Q2 2021. 303 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Amalgamated Bank held 27,706 shares of Jazz Pharmaceuticals worth $6.68M as of Q2 2026.
  • Amalgamated Bank sold 1,905 Jazz Pharmaceuticals shares in Q2 2026, an estimated $417K.
  • Jazz Pharmaceuticals made up 0.05% of Amalgamated Bank's portfolio in Q2 2026, its #322 holding.
  • Amalgamated Bank first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 43 quarters since.
  • Amalgamated Bank's Jazz Pharmaceuticals position peaked at $8.73M in Q2 2021.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.